Published July 14, 2021 | Version Accepted Version

Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models

Description

This is the accepted manuscript version of the work published in its final form as Wu, L., Vasilijic, S., Sun, Y., Chen, J., Landegger, L. D., Zhang, Y., Zhou, W., Ren, J., Early, S., Yin, Z., Ho, W. W., Zhang, N., Gao, X., Lee, G. Y., Datta, M., Sagers, J. E., Brown, A., Muzikansky, A., Stemmer-Rachamimov, A., ... Xu, L. (2021). Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models. Science Translational Medicine, 13(602). https://doi.org/10.1126/scitranslmed.abd4816

Deposited by shareyourpaper.org and openaccessbutton.org. We've taken reasonable steps to ensure this content doesn't violate copyright. However, if you think it does you can request a takedown by emailing help@openaccessbutton.org.

Files

abd4816_ArticleContent_v2_0519.pdf

Files (405.8 kB)

Name Size
md5:0be9494b79eb040b6147fa598deff3ee
405.8 kB Preview Download

Additional details

Related works

Is identical to
10.1126/scitranslmed.abd4816 (DOI)